Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2003
05/30/2003CA2468235A1 Nucleic acid linkers and their use in gene synthesis
05/30/2003CA2468170A1 Method for identification of tumor targeting enzymes
05/30/2003CA2468145A1 Transcriptional factors for the huntington's disease gene
05/30/2003CA2468107A1 Methods for identifying and validating potential drug targets
05/30/2003CA2468096A1 Method for production of asymmetric carotenoids
05/30/2003CA2468088A1 Novel peptides conferring environmental stress resistance and fusion proteins including said peptides
05/30/2003CA2467958A1 Recovery of recombinant human parainfluenza virus type 1 (hpivi) from cdna
05/30/2003CA2467936A1 Method of inhibiting gene expression
05/30/2003CA2467930A1 Treatment of pml targeting jc virus agno
05/30/2003CA2467927A1 Antimicrobial polypeptides from pseudoplectania nigrella
05/30/2003CA2467908A1 Mfg-e8-l regulates phagocytic removal of apoptotic cells by macrophages
05/30/2003CA2467717A1 Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases
05/30/2003CA2467577A1 Multiplex pcr
05/30/2003CA2467563A1 Cell and tissue arrays and microarrays and methods of use
05/30/2003CA2467460A1 Multiplex oligonucleotide addition and target amplification
05/30/2003CA2467455A1 Method of detection of prostate cancer
05/30/2003CA2467248A1 Automated sample preparation methods and devices
05/30/2003CA2467206A1 Genes encoding g-protein coupled receptors and methods of use therefor
05/30/2003CA2467053A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/30/2003CA2467050A1 Method for detecting analyte(s) using magnetic colloidal particles
05/30/2003CA2467020A1 Tumor specific monoclonal antibodies
05/30/2003CA2466937A1 Methylated heparin-binding hemagglutinin (hbha) recombinant mycobacterial antigen
05/30/2003CA2464957A1 Polypeptides of moraxella (branhamella) catarrhalis
05/30/2003CA2464542A1 Composition comprising and method of using angiopoietin-like protein 3 angptl3
05/30/2003CA2463790A1 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/30/2003CA2462819A1 Method and kit for proximity probing with multivalent proximity probes
05/30/2003CA2445078A1 Chimeric plasmid comprising a replicative retroviral genome and uses thereof
05/30/2003CA2411208A1 Vector encoding suicide and marker constructs
05/30/2003CA2407302A1 Genes transfection into bony tissues
05/30/2003CA2364043A1 Methylotrophic bacterium for the production of recombinant proteins and other products
05/29/2003US20030101489 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
05/29/2003US20030101488 Nucleotide sequences coding lyase for use in controlling aging and apoptosis in plants
05/29/2003US20030101487 Generation of genetically engineered tomatoes containing high concentrations of glutamic acid, asparagine, aspartic acid, serine, threonine, alanine and histidine
05/29/2003US20030101486 Schizochytrium PKS genes
05/29/2003US20030101485 Oligonucleotides for use in gene expression inhibition in plants
05/29/2003US20030101484 Maize chitinases and their use in enhancing disease resistance in crop plants
05/29/2003US20030101483 Regulatory nucleotide sequences for use in the generation of disease resistant plants
05/29/2003US20030101482 Compositions encoding lepidopteran-toxic polypeptides and methods of use
05/29/2003US20030101480 Artificial chromosomes, uses therof and methods for preparing artificial chromosomes
05/29/2003US20030101479 Constitutive photomorphogenesis 1 (COP1) nucleic acid sequence from Zea mays and its use thereof
05/29/2003US20030101478 Compositions and methods for the modification of gene expression
05/29/2003US20030101477 Generation of transgenic cells with amplified naringenin and kaempferol concentrations
05/29/2003US20030101476 Recombinant phytases and uses thereof
05/29/2003US20030101475 Novel constitutive and tissue specific plant promoters and their utilization
05/29/2003US20030101474 Regulatory sequences associated with the control of gene expression in plants
05/29/2003US20030101472 Generation of genetically engineered cells using retroviral vector; for use in generation of disease models
05/29/2003US20030101471 Method for producing transgenic birds and fish
05/29/2003US20030101470 Animal model for use in diagnosis, prevention and treatment of bone, splenic, blood, inflammatory and nervous system disorders
05/29/2003US20030101469 Cloned non-human mammals from contact inhibited donor cells
05/29/2003US20030101468 Unactivated oocytes as cytoplast recipients for nuclear transfer
05/29/2003US20030101467 Genetically engineered vector coding amyloid precursor protein for use in treatment of nervous system disorders
05/29/2003US20030101465 Universal stem cells
05/29/2003US20030101001 Identifying sequence motifs characteristic of G-protein-coupled receptor subfamilies and using these motifs to classify "orphan GPCRs"
05/29/2003US20030100748 Regulatory sequences for use in expression of transgenes
05/29/2003US20030100745 Antibody for 4-1BB
05/29/2003US20030100743 Nucleic acids and proteins with thioredoxin reductase activity
05/29/2003US20030100741 Immunoglobulin protein for use in the treatment and prevention of viral infections and diseasee; viricides
05/29/2003US20030100740 Protein for use in the treatment of blood disorders
05/29/2003US20030100709 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
05/29/2003US20030100707 Chimeric protein for use in the treatment of viral and nervous system disorders
05/29/2003US20030100706 Nucleotide sequences coding polypeptide for use in the prevention and treatment of bacterial infections
05/29/2003US20030100705 Use of alkanes for contamination-free purification or separation of biopolymers
05/29/2003US20030100531 8-30 nucleotides with 2' modified sugar moiety targeted to a nucleic acid molecule encoding human Interleukin-15, hybridizes and inhibits expression; anticancer agents and treating autoimmune diseases
05/29/2003US20030100528 Isolated polynucleotides having a reduced or an increased content of epigenetic control motifs and uses thereof
05/29/2003US20030100526 Operably linked mammalian muscle creatine kinase promoter, mammalian desmin promoter and enhancers thereof, and vertebrate troponin I IRE enhancer; gene therapy
05/29/2003US20030100525 Amino acid sequences; anticaner agents, monitoring, diagnosis
05/29/2003US20030100524 Inhibiting expression with 8-50 nucleobases that hydridizes to the encoding nucleic acid molecule; treating autoimmune diseases; antiinflammatory agents
05/29/2003US20030100523 Adenoviruses for control of gene expression
05/29/2003US20030100522 Antisense modulation of ribonuclease L expression
05/29/2003US20030100521 For therapy of HIV infection
05/29/2003US20030100519 Using polyamide nucleic acid oligomers to engender a biological response
05/29/2003US20030100508 Carbohydrate epitope mimic compounds and uses thereof
05/29/2003US20030100504 Treatment and diagnosis of insulin-resistant states
05/29/2003US20030100503 Neurogenic compositions and methods
05/29/2003US20030100496 Compositions and methods for highly efficient transfection
05/29/2003US20030100491 Novel proteins and nucleic acids encoding same
05/29/2003US20030100489 For determining if a subject is at risk for a disorder characterized by unwanted cell proliferation
05/29/2003US20030100488 Osteoprotegerin binding proteins
05/29/2003US20030100484 Cell in which a urotensin II receptor is formed is contacted with a chemical compound; activity or quantity of a gene, or its gene product, from the cell from is determined, comparing with gene product of control cell
05/29/2003US20030100483 As preservatives; in prophylaxis and therapy of viral or microbial infection in animals and plants, and in inactivating endotoxin
05/29/2003US20030100480 Methods and compositions for modulating sebaceous glands
05/29/2003US20030100116 Canine adenovirus vectors for the transfer of genes in targeted cells
05/29/2003US20030100115 Killing cells that lack tumor suppressor proteins; obtain cells, transform with preferential single stranded nucleotide sequence, monitor viability of cells
05/29/2003US20030100114 Methods for regulating T cell subsets by modulating transcription factor activity
05/29/2003US20030100113 Plasmids for use in the transfer of nucleotide sequences into cells
05/29/2003US20030100112 Expression vector for use as tool in the expression of exogenous nucleotide sequences in eukaryotic cells
05/29/2003US20030100111 To produce array of transfected cells
05/29/2003US20030100110 Vector for use as a propagation tool in genetic engineering
05/29/2003US20030100106 Baculovirus produced Plasmodium falciparum vaccine
05/29/2003US20030100102 Apparatus and method for sequencing a nucleic acid
05/29/2003US20030100100 Insertional mutations in mycobacteria
05/29/2003US20030100095 New human cathepsin
05/29/2003US20030100093 Human telomerase catalytic subunit: diagnostic and therapeutic methods
05/29/2003US20030100092 For reducing the phospholipid content of an aqueous carbohydrate solution or slurry; used in dough
05/29/2003US20030100091 Metalloprotease-disintegrin ADAM23 (SVPH3-17)
05/29/2003US20030100089 Protein for use in the treatment of angiogeneic, tumor, apoptotic, inflammatory, blood, viral, liver respiratory, arthritic and skin disorders
05/29/2003US20030100087 Nucleotide sequences coding protein for use in the diagnosis, prevention and treatment of tumors and cell profiferative disorders
05/29/2003US20030100081 Process for the preparation of D-pantothenic acid and/or salts thereof
05/29/2003US20030100079 Novel nucleotide sequences coding for the genes sdhA, sdhB and sdhC
05/29/2003US20030100077 In vitro method to create circular molecules for use in transformation
1 ... 2507 2508 2509 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 ... 4023